|
Fusion gene ID: 37058 |
FusionGeneSummary for TADA2A_MYO1D |
Fusion gene summary |
Fusion gene information | Fusion gene name: TADA2A_MYO1D | Fusion gene ID: 37058 | Hgene | Tgene | Gene symbol | TADA2A | MYO1D | Gene ID | 6871 | 4642 |
Gene name | transcriptional adaptor 2A | myosin ID | |
Synonyms | ADA2|ADA2A|KL04P|TADA2L|hADA2 | PPP1R108|myr4 | |
Cytomap | 17q12 | 17q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | transcriptional adapter 2-alphaADA2-like proteintranscriptional adaptor 2 alpha | unconventional myosin-Idmyosin-I gammaprotein phosphatase 1, regulatory subunit 108 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | O75478 | O94832 | |
Ensembl transtripts involved in fusion gene | ENST00000394395, ENST00000586023, ENST00000225396, ENST00000417170, ENST00000591992, | ENST00000318217, ENST00000394649, ENST00000579584, ENST00000584232, ENST00000583621, | |
Fusion gene scores | * DoF score | 10 X 9 X 6=540 | 15 X 9 X 8=1080 |
# samples | 10 | 15 | |
** MAII score | log2(10/540*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1080*10)=-2.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TADA2A [Title/Abstract] AND MYO1D [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TADA2A | GO:0043966 | histone H3 acetylation | 9674425 |
Tgene | MYO1D | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-D8-A1J9-01A | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000394395 | ENST00000318217 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
Frame-shift | ENST00000394395 | ENST00000394649 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000394395 | ENST00000579584 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000394395 | ENST00000584232 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000394395 | ENST00000583621 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
In-frame | ENST00000586023 | ENST00000318217 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
Frame-shift | ENST00000586023 | ENST00000394649 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000586023 | ENST00000579584 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000586023 | ENST00000584232 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000586023 | ENST00000583621 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
In-frame | ENST00000225396 | ENST00000318217 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
Frame-shift | ENST00000225396 | ENST00000394649 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000225396 | ENST00000579584 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000225396 | ENST00000584232 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000225396 | ENST00000583621 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
In-frame | ENST00000417170 | ENST00000318217 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
Frame-shift | ENST00000417170 | ENST00000394649 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000417170 | ENST00000579584 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000417170 | ENST00000584232 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
5CDS-intron | ENST00000417170 | ENST00000583621 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
3UTR-3CDS | ENST00000591992 | ENST00000318217 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
3UTR-3CDS | ENST00000591992 | ENST00000394649 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
3UTR-intron | ENST00000591992 | ENST00000579584 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
3UTR-intron | ENST00000591992 | ENST00000584232 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
3UTR-intron | ENST00000591992 | ENST00000583621 | TADA2A | chr17 | 35802753 | + | MYO1D | chr17 | 30821933 | - |
Top |
FusionProtFeatures for TADA2A_MYO1D |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
TADA2A | MYO1D |
Component of the ATAC complex, a complex with histoneacetyltransferase activity on histones H3 and H4. Required for thefunction of some acidic activation domains, which activatetranscription from a distant site (By similarity). Binds double-stranded DNA. Binds dinucleosomes, probably at the linker regionbetween neighboring nucleosomes. Plays a role in chromatinremodeling. May promote TP53/p53 'Lys-321' acetylation, leading toreduced TP53 stability and transcriptional activity(PubMed:22644376). May also promote XRCC6 acetylation thusfacilitating cell apoptosis in response to DNA damage(PubMed:22644376). {ECO:0000250|UniProtKB:Q8CHV6,ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:22644376}. | Myosins are actin-based motor molecules with ATPaseactivity. Unconventional myosins serve in intracellular movements.Their highly divergent tails are presumed to bind to membranouscompartments, which would be moved relative to actin filaments (Bysimilarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000225396 | + | 7 | 16 | 17_45 | 177 | 444 | Compositional bias | Note=Cys-rich |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000394395 | + | 7 | 16 | 17_45 | 177 | 444 | Compositional bias | Note=Cys-rich |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000417170 | + | 7 | 11 | 17_45 | 177 | 306 | Compositional bias | Note=Cys-rich |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000586023 | + | 7 | 11 | 17_45 | 177 | 306 | Compositional bias | Note=Cys-rich |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000225396 | + | 7 | 16 | 70_122 | 177 | 444 | Domain | SANT |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000394395 | + | 7 | 16 | 70_122 | 177 | 444 | Domain | SANT |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000417170 | + | 7 | 11 | 70_122 | 177 | 306 | Domain | SANT |
Hgene | TADA2A | chr17:35802753 | chr17:30821933 | ENST00000586023 | + | 7 | 11 | 70_122 | 177 | 306 | Domain | SANT |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000225396 | + | 7 | 16 | 426_435 | 177 | 444 | DNA binding | Ontology_term=ECO:0000250 |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000394395 | + | 7 | 16 | 426_435 | 177 | 444 | DNA binding | Ontology_term=ECO:0000250 |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000417170 | + | 7 | 11 | 426_435 | 177 | 306 | DNA binding | Ontology_term=ECO:0000250 |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000586023 | + | 7 | 11 | 426_435 | 177 | 306 | DNA binding | Ontology_term=ECO:0000250 |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000225396 | + | 7 | 16 | 356_443 | 177 | 444 | Domain | SWIRM |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000394395 | + | 7 | 16 | 356_443 | 177 | 444 | Domain | SWIRM |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000417170 | + | 7 | 11 | 356_443 | 177 | 306 | Domain | SWIRM |
Hgene | >TADA2A | chr17:35802753 | chr17:30821933 | ENST00000586023 | + | 7 | 11 | 356_443 | 177 | 306 | Domain | SWIRM |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 699_719 | 954 | 1007 | Domain | IQ 1 |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 721_741 | 954 | 1007 | Domain | IQ 2 |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 812_1005 | 954 | 1007 | Domain | TH1 |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 9_695 | 954 | 1007 | Domain | Myosin motor |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 102_109 | 954 | 1007 | Nucleotide binding | ATP |
Tgene | MYO1D | chr17:35802753 | chr17:30821933 | ENST00000318217 | - | 20 | 22 | 572_594 | 954 | 1007 | Region | Actin-binding |
Top |
FusionGeneSequence for TADA2A_MYO1D |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_TADA2A_ENST00000394395_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_229aa MDRLGPFSNDPSDKPPCRGCSSYLMEPYIKCAECGPPPFFLCLQCFTRGFEYKKHQSDHTYEIMTSDFPVLDPSWTAQEEMALLEAVMDC GFGNWQDVANQMCTKTKEECEKHYMKHFINNPLFASTLLNLKQAEEAKTADTAIPFHSTDDPPRPTFDSLLSRDMAGYMPARADFIEXEA >In-frame_TADA2A_ENST00000586023_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_229aa MDRLGPFSNDPSDKPPCRGCSSYLMEPYIKCAECGPPPFFLCLQCFTRGFEYKKHQSDHTYEIMTSDFPVLDPSWTAQEEMALLEAVMDC GFGNWQDVANQMCTKTKEECEKHYMKHFINNPLFASTLLNLKQAEEAKTADTAIPFHSTDDPPRPTFDSLLSRDMAGYMPARADFIEXEA >In-frame_TADA2A_ENST00000225396_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_229aa MDRLGPFSNDPSDKPPCRGCSSYLMEPYIKCAECGPPPFFLCLQCFTRGFEYKKHQSDHTYEIMTSDFPVLDPSWTAQEEMALLEAVMDC GFGNWQDVANQMCTKTKEECEKHYMKHFINNPLFASTLLNLKQAEEAKTADTAIPFHSTDDPPRPTFDSLLSRDMAGYMPARADFIEXEA >In-frame_TADA2A_ENST00000417170_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_229aa MDRLGPFSNDPSDKPPCRGCSSYLMEPYIKCAECGPPPFFLCLQCFTRGFEYKKHQSDHTYEIMTSDFPVLDPSWTAQEEMALLEAVMDC GFGNWQDVANQMCTKTKEECEKHYMKHFINNPLFASTLLNLKQAEEAKTADTAIPFHSTDDPPRPTFDSLLSRDMAGYMPARADFIEXEA |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_TADA2A_ENST00000394395_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_688nt ATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCTTATATCAAG TGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGCGATCATACT TATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTGATGGACTGT GGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCATTTCATCAAT AACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCACTCTACAGAT GACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAGTGAGAAGCG CCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCTCAACCAGCC >In-frame_TADA2A_ENST00000586023_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_688nt ATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCTTATATCAAG TGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGCGATCATACT TATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTGATGGACTGT GGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCATTTCATCAAT AACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCACTCTACAGAT GACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAGTGAGAAGCG CCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCTCAACCAGCC >In-frame_TADA2A_ENST00000225396_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_688nt ATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCTTATATCAAG TGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGCGATCATACT TATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTGATGGACTGT GGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCATTTCATCAAT AACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCACTCTACAGAT GACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAGTGAGAAGCG CCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCTCAACCAGCC >In-frame_TADA2A_ENST00000417170_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_688nt ATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCTTATATCAAG TGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGCGATCATACT TATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTGATGGACTGT GGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCATTTCATCAAT AACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCACTCTACAGAT GACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAGTGAGAAGCG CCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCTCAACCAGCC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_TADA2A_ENST00000394395_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_3098nt CCGGGGGCGCGCACGCAAAGCCCGGAGGCGCGCGCGACCGGCGGCTCTTTGGCGCGGATTAGGGGGTCTCGGCGAGGGAGTCATCAAGCT TTGGTGTATGTGTTGGCCGGTTCTGAAGTCTTGAAGAAGCTCTGCTGAGGAAGACCAAAGCAGCACTCGTTGCCAATTAGGGAATGGACC GTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCTTATATCAAGTGTGCTG AATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGCGATCATACTTATGAAA TAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTGATGGACTGTGGCTTTG GAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCATTTCATCAATAACCCTC TGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCACTCTACAGATGACCCTC CCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAGTGAGAAGCGCCACCTT CAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCTCAACCAGCCCCAGCCC GACTTCACCAAGAATCGCTCGGGCTTCATCCTCAGCGTGCCCGGGAACTGACGCCCCGCGGAGGCCTGGCCCGGAGCCCGGCCACACTCC GAGTCCTGGGTCCCAGTCCAGCTGCTGCCTCCCAACCCATGCCCGCTAGAAACCTGCTGCGAGGGCCCCTCCCAGAGGAGCCCCGCCCCT GTAAGATTTCCTTCCTGGTTTTCTGCCTTTGGTATCATCTTCCTCTGTCCTTACTGTCCACGGTCCCTGTTCAATAAGCCAAAGACCCTG GTGCCCCGCCCAGACCCCTGGGCTGACGTCCAGACCAATCTCACCCCAGAGGCAACTGGATGGTGCCTTTAGTTGGTGCGGATGCCCCGT GGCCAGGTCAAGTCAGAGCACCTGGACAGGTGTCCTCCCTGCTGCTGACCCTGCAGAGGGAAGGGGTGGGGATGCAGGACCCCACTCTGC GGGAGCCCCATAGCCACCTCTCTTGCCCAAGGTGAGCCAGCCCTGGGGACCCAGCTCAGGGAGGCTCTGCTCAGAGTTCGGCGGACCCAC CCCAACCCAACTCCCAGCCGCCAGCCAAAGCCACTGGGTGAGCAGAGTCACCCACAGGGCCAGCCCCTCAGCCAGGAGCCAGTGGCAGGA GCGGAACAGCCCATCCAGCAGAGTGAGTCCATCCTTCCCAGGTTCTCCCCTGGGAGACTCCCTTTGCCACCAAGGCCCCCACCAGGGCCT CTGACCACCGCTCTGGAGAGGACAGTGTGGCATGCTCCAAGGATCATCTTACTTAACTCGCAGCCTGTGGCTGTGGTCCTCTTATAGATA CTTTCACCGTTTGCAGGGTTGCTAATCAGATACCTGCTGTCACCACACTTGGGTCAGGAACCCTAATGAGAACGGGGAGCTGCCAGGGTG AGGGCAGCCCTCAGGGTCGGCCGCTTTCCCTCTGGACCACCTCCCGCTGCGTTTCCTACTCAGAGAAACAGCAAGGGCGGGGTCAAGACA CGGGATGACGGGAAGCAGGAAGCGGGGCAGCAGCACAGCGTGGGGTCCTGGCACTGCAGGCCAGGCCAGGATGCCCACCCCGCCCTCTAC ACGGCCCCTTGGGGCCTGCGCCCGTGAAACTGGTGCCAGGGAGCACTGCCAGCTTGCCAGTTTCTGCCCAGCAAAAGCACGTATGCTTCA GGGGCCTTCTGAGACCACCTTCCCCACTGAGCCCCAGCTGCTGAGAAGGCCTTGAGGGAAGTAGAGGCTGGGAGCAAATGCCCCATGCGG TGAGAGGATGAGGGGAGCCTACGCCTCAGGCATGTGGTGAGAGGATGAGGGGGAGGGAGCCAACGCCTCAGGTGGAGTGGGCAGAGGTGC AAGAGAGGGATGTACTGAAGCTTCTTCCCGTCCTGCCACAGACACTTCTCCTGCCTTCCCACCCTGACCCGGCAGAACCCACCAAGTGCC TGTGTGCAGCCTCCTGTGCCTCACCCAGGGCCTGACCCCAGAGTGGTCCCAACAACCCGGTCTCATGCCCACTCCCCATCCCTGCTTCCC AAAAATTGCACTGTGTGCAGTTTGCAACAAAGAATCCCGCTGGCATCCTGTCCTTGGGAACCCTTTCTCATTCTCCAAGCCTGGTCAGCT GCCTGCACAGGCAGAGGTGCCCTCAGCCCAGATTAGCAACACTCATAGTTTTGCCAATTACCAGTAGACACTAGTGGAACCATCTAACTG GAACTTCCTCTCTCCTTCCACTTATTTCCTCAAACTTGTTGCTTTACACTAGACACATGCAAATGTATGTTTTAAACACACCAAAACAGA TCATGCCAAATGAGTTGCCTGTCAAAGGCTGGAGGGCAGGAGGAGGGCCTGGGTTTGGGTTCTTTCCTCCCAGCCTTTGGATGGTGCCTT GGGCCCCTTAGCCCCAGCGCCAGGGCCTCCCAGCTGAGGCCACAGGACAAGCACTTTTTTATGATGTACTAAAAGCCACAGTATGTGGCA ACTGCAAAAGGATCAGGAATTTAGGGTATGATCTCGGTCACGTGTCCCGGGCGCTGAGGGGAAAGGAAGCGGGCATGATTGTAGACAATG AGGGGGTTCTCTTGATGTAATGAAATGCAATTTTATGGTTTGGTGCAAAAACTCCTATTTTCCAGTAAATTAACTTTATTTCTAAAGCAT ATTTTGATTTGCCATCAAGAGCAATAAAGCATTAAATCTTATTTTTAAAGGTGTTCTGCTTATCTGTCACTGAAAACTTGGTGAAATTTT >In-frame_TADA2A_ENST00000586023_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_3033nt GTCTCGGCGAGGGAGTCATCAAGCTTTGGTGTATGTGTTGGCCGGTTCTGAAGTCTTGAAGAAGCTCTGCTGAGGAAGACCAAAGCAGCA CTCGTTGCCAATTAGGGAATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTC ATGGAGCCTTATATCAAGTGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAA CATCAAAGCGATCATACTTATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTA GAAGCTGTGATGGACTGTGGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTAT ATGAAGCATTTCATCAATAACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATT CCATTTCACTCTACAGATGACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGAT TTCATTGAGTGAGAAGCGCCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGA GACGCGGCTCAACCAGCCCCAGCCCGACTTCACCAAGAATCGCTCGGGCTTCATCCTCAGCGTGCCCGGGAACTGACGCCCCGCGGAGGC CTGGCCCGGAGCCCGGCCACACTCCGAGTCCTGGGTCCCAGTCCAGCTGCTGCCTCCCAACCCATGCCCGCTAGAAACCTGCTGCGAGGG CCCCTCCCAGAGGAGCCCCGCCCCTGTAAGATTTCCTTCCTGGTTTTCTGCCTTTGGTATCATCTTCCTCTGTCCTTACTGTCCACGGTC CCTGTTCAATAAGCCAAAGACCCTGGTGCCCCGCCCAGACCCCTGGGCTGACGTCCAGACCAATCTCACCCCAGAGGCAACTGGATGGTG CCTTTAGTTGGTGCGGATGCCCCGTGGCCAGGTCAAGTCAGAGCACCTGGACAGGTGTCCTCCCTGCTGCTGACCCTGCAGAGGGAAGGG GTGGGGATGCAGGACCCCACTCTGCGGGAGCCCCATAGCCACCTCTCTTGCCCAAGGTGAGCCAGCCCTGGGGACCCAGCTCAGGGAGGC TCTGCTCAGAGTTCGGCGGACCCACCCCAACCCAACTCCCAGCCGCCAGCCAAAGCCACTGGGTGAGCAGAGTCACCCACAGGGCCAGCC CCTCAGCCAGGAGCCAGTGGCAGGAGCGGAACAGCCCATCCAGCAGAGTGAGTCCATCCTTCCCAGGTTCTCCCCTGGGAGACTCCCTTT GCCACCAAGGCCCCCACCAGGGCCTCTGACCACCGCTCTGGAGAGGACAGTGTGGCATGCTCCAAGGATCATCTTACTTAACTCGCAGCC TGTGGCTGTGGTCCTCTTATAGATACTTTCACCGTTTGCAGGGTTGCTAATCAGATACCTGCTGTCACCACACTTGGGTCAGGAACCCTA ATGAGAACGGGGAGCTGCCAGGGTGAGGGCAGCCCTCAGGGTCGGCCGCTTTCCCTCTGGACCACCTCCCGCTGCGTTTCCTACTCAGAG AAACAGCAAGGGCGGGGTCAAGACACGGGATGACGGGAAGCAGGAAGCGGGGCAGCAGCACAGCGTGGGGTCCTGGCACTGCAGGCCAGG CCAGGATGCCCACCCCGCCCTCTACACGGCCCCTTGGGGCCTGCGCCCGTGAAACTGGTGCCAGGGAGCACTGCCAGCTTGCCAGTTTCT GCCCAGCAAAAGCACGTATGCTTCAGGGGCCTTCTGAGACCACCTTCCCCACTGAGCCCCAGCTGCTGAGAAGGCCTTGAGGGAAGTAGA GGCTGGGAGCAAATGCCCCATGCGGTGAGAGGATGAGGGGAGCCTACGCCTCAGGCATGTGGTGAGAGGATGAGGGGGAGGGAGCCAACG CCTCAGGTGGAGTGGGCAGAGGTGCAAGAGAGGGATGTACTGAAGCTTCTTCCCGTCCTGCCACAGACACTTCTCCTGCCTTCCCACCCT GACCCGGCAGAACCCACCAAGTGCCTGTGTGCAGCCTCCTGTGCCTCACCCAGGGCCTGACCCCAGAGTGGTCCCAACAACCCGGTCTCA TGCCCACTCCCCATCCCTGCTTCCCAAAAATTGCACTGTGTGCAGTTTGCAACAAAGAATCCCGCTGGCATCCTGTCCTTGGGAACCCTT TCTCATTCTCCAAGCCTGGTCAGCTGCCTGCACAGGCAGAGGTGCCCTCAGCCCAGATTAGCAACACTCATAGTTTTGCCAATTACCAGT AGACACTAGTGGAACCATCTAACTGGAACTTCCTCTCTCCTTCCACTTATTTCCTCAAACTTGTTGCTTTACACTAGACACATGCAAATG TATGTTTTAAACACACCAAAACAGATCATGCCAAATGAGTTGCCTGTCAAAGGCTGGAGGGCAGGAGGAGGGCCTGGGTTTGGGTTCTTT CCTCCCAGCCTTTGGATGGTGCCTTGGGCCCCTTAGCCCCAGCGCCAGGGCCTCCCAGCTGAGGCCACAGGACAAGCACTTTTTTATGAT GTACTAAAAGCCACAGTATGTGGCAACTGCAAAAGGATCAGGAATTTAGGGTATGATCTCGGTCACGTGTCCCGGGCGCTGAGGGGAAAG GAAGCGGGCATGATTGTAGACAATGAGGGGGTTCTCTTGATGTAATGAAATGCAATTTTATGGTTTGGTGCAAAAACTCCTATTTTCCAG TAAATTAACTTTATTTCTAAAGCATATTTTGATTTGCCATCAAGAGCAATAAAGCATTAAATCTTATTTTTAAAGGTGTTCTGCTTATCT >In-frame_TADA2A_ENST00000225396_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_3295nt ATTTCCCGCTCAGCCCTGGAGCGCGTAGCTCTACCAAGAATGGCCACTGTGCCAGATGCCCCTGACCAGCGTTGCCCATTTGAATTTCCT AGCAGGCCCCCCAAAGTAGGTATTTCAGTACCCTGTTAGAGCTGAGGCGCAGGTAAAATGACTGGCCCAGGCCGGTCCCACCCCGTAAGG ATTTGAACGTTGGCTCCACAACTCGGGAGCCTGCGCCTTTCCTCCTCCCAACGTGGACTCCTGCCCGGCGAAGTGCCTCACTTCCTTCTC CCGGGAGTCATCAAGCTTTGGTGTATGTGTTGGCCGGTTCTGAAGTCTTGAAGAAGCTCTGCTGAGGAAGACCAAAGCAGCACTCGTTGC CAATTAGGGAATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCC TTATATCAAGTGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAG CGATCATACTTATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGT GATGGACTGTGGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCA TTTCATCAATAACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCA CTCTACAGATGACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGA GTGAGAAGCGCCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGC TCAACCAGCCCCAGCCCGACTTCACCAAGAATCGCTCGGGCTTCATCCTCAGCGTGCCCGGGAACTGACGCCCCGCGGAGGCCTGGCCCG GAGCCCGGCCACACTCCGAGTCCTGGGTCCCAGTCCAGCTGCTGCCTCCCAACCCATGCCCGCTAGAAACCTGCTGCGAGGGCCCCTCCC AGAGGAGCCCCGCCCCTGTAAGATTTCCTTCCTGGTTTTCTGCCTTTGGTATCATCTTCCTCTGTCCTTACTGTCCACGGTCCCTGTTCA ATAAGCCAAAGACCCTGGTGCCCCGCCCAGACCCCTGGGCTGACGTCCAGACCAATCTCACCCCAGAGGCAACTGGATGGTGCCTTTAGT TGGTGCGGATGCCCCGTGGCCAGGTCAAGTCAGAGCACCTGGACAGGTGTCCTCCCTGCTGCTGACCCTGCAGAGGGAAGGGGTGGGGAT GCAGGACCCCACTCTGCGGGAGCCCCATAGCCACCTCTCTTGCCCAAGGTGAGCCAGCCCTGGGGACCCAGCTCAGGGAGGCTCTGCTCA GAGTTCGGCGGACCCACCCCAACCCAACTCCCAGCCGCCAGCCAAAGCCACTGGGTGAGCAGAGTCACCCACAGGGCCAGCCCCTCAGCC AGGAGCCAGTGGCAGGAGCGGAACAGCCCATCCAGCAGAGTGAGTCCATCCTTCCCAGGTTCTCCCCTGGGAGACTCCCTTTGCCACCAA GGCCCCCACCAGGGCCTCTGACCACCGCTCTGGAGAGGACAGTGTGGCATGCTCCAAGGATCATCTTACTTAACTCGCAGCCTGTGGCTG TGGTCCTCTTATAGATACTTTCACCGTTTGCAGGGTTGCTAATCAGATACCTGCTGTCACCACACTTGGGTCAGGAACCCTAATGAGAAC GGGGAGCTGCCAGGGTGAGGGCAGCCCTCAGGGTCGGCCGCTTTCCCTCTGGACCACCTCCCGCTGCGTTTCCTACTCAGAGAAACAGCA AGGGCGGGGTCAAGACACGGGATGACGGGAAGCAGGAAGCGGGGCAGCAGCACAGCGTGGGGTCCTGGCACTGCAGGCCAGGCCAGGATG CCCACCCCGCCCTCTACACGGCCCCTTGGGGCCTGCGCCCGTGAAACTGGTGCCAGGGAGCACTGCCAGCTTGCCAGTTTCTGCCCAGCA AAAGCACGTATGCTTCAGGGGCCTTCTGAGACCACCTTCCCCACTGAGCCCCAGCTGCTGAGAAGGCCTTGAGGGAAGTAGAGGCTGGGA GCAAATGCCCCATGCGGTGAGAGGATGAGGGGAGCCTACGCCTCAGGCATGTGGTGAGAGGATGAGGGGGAGGGAGCCAACGCCTCAGGT GGAGTGGGCAGAGGTGCAAGAGAGGGATGTACTGAAGCTTCTTCCCGTCCTGCCACAGACACTTCTCCTGCCTTCCCACCCTGACCCGGC AGAACCCACCAAGTGCCTGTGTGCAGCCTCCTGTGCCTCACCCAGGGCCTGACCCCAGAGTGGTCCCAACAACCCGGTCTCATGCCCACT CCCCATCCCTGCTTCCCAAAAATTGCACTGTGTGCAGTTTGCAACAAAGAATCCCGCTGGCATCCTGTCCTTGGGAACCCTTTCTCATTC TCCAAGCCTGGTCAGCTGCCTGCACAGGCAGAGGTGCCCTCAGCCCAGATTAGCAACACTCATAGTTTTGCCAATTACCAGTAGACACTA GTGGAACCATCTAACTGGAACTTCCTCTCTCCTTCCACTTATTTCCTCAAACTTGTTGCTTTACACTAGACACATGCAAATGTATGTTTT AAACACACCAAAACAGATCATGCCAAATGAGTTGCCTGTCAAAGGCTGGAGGGCAGGAGGAGGGCCTGGGTTTGGGTTCTTTCCTCCCAG CCTTTGGATGGTGCCTTGGGCCCCTTAGCCCCAGCGCCAGGGCCTCCCAGCTGAGGCCACAGGACAAGCACTTTTTTATGATGTACTAAA AGCCACAGTATGTGGCAACTGCAAAAGGATCAGGAATTTAGGGTATGATCTCGGTCACGTGTCCCGGGCGCTGAGGGGAAAGGAAGCGGG CATGATTGTAGACAATGAGGGGGTTCTCTTGATGTAATGAAATGCAATTTTATGGTTTGGTGCAAAAACTCCTATTTTCCAGTAAATTAA CTTTATTTCTAAAGCATATTTTGATTTGCCATCAAGAGCAATAAAGCATTAAATCTTATTTTTAAAGGTGTTCTGCTTATCTGTCACTGA >In-frame_TADA2A_ENST00000417170_chr17_35802753_+_MYO1D_ENST00000318217_chr17_30821933_-_3294nt TTTCCCGCTCAGCCCTGGAGCGCGTAGCTCTACCAAGAATGGCCACTGTGCCAGATGCCCCTGACCAGCGTTGCCCATTTGAATTTCCTA GCAGGCCCCCCAAAGTAGGTATTTCAGTACCCTGTTAGAGCTGAGGCGCAGGTAAAATGACTGGCCCAGGCCGGTCCCACCCCGTAAGGA TTTGAACGTTGGCTCCACAACTCGGGAGCCTGCGCCTTTCCTCCTCCCAACGTGGACTCCTGCCCGGCGAAGTGCCTCACTTCCTTCTCC CGGGAGTCATCAAGCTTTGGTGTATGTGTTGGCCGGTTCTGAAGTCTTGAAGAAGCTCTGCTGAGGAAGACCAAAGCAGCACTCGTTGCC AATTAGGGAATGGACCGTTTGGGTCCCTTTAGCAATGATCCCTCTGATAAGCCACCTTGCCGAGGCTGCTCCTCCTACCTCATGGAGCCT TATATCAAGTGTGCTGAATGTGGGCCACCTCCTTTTTTCCTCTGCTTGCAGTGTTTCACTCGAGGCTTTGAGTACAAGAAACATCAAAGC GATCATACTTATGAAATAATGACTTCAGATTTTCCTGTCCTTGATCCCAGCTGGACTGCTCAAGAAGAAATGGCCCTTTTAGAAGCTGTG ATGGACTGTGGCTTTGGAAATTGGCAGGATGTAGCCAATCAAATGTGCACCAAGACCAAGGAGGAGTGTGAGAAGCACTATATGAAGCAT TTCATCAATAACCCTCTGTTTGCATCTACCCTGCTGAACCTGAAACAAGCAGAGGAAGCAAAAACTGCTGACACAGCCATTCCATTTCAC TCTACAGATGACCCTCCCCGACCTACCTTTGACTCCTTGCTTTCTCGGGACATGGCCGGGTACATGCCAGCTCGAGCAGATTTCATTGAG TGAGAAGCGCCACCTTCAAGTGAACGTCACCAACCCAGTACAGTGCAGCCTGCACGGGAAGAAGTGCACCGTCTCCGTGGAGACGCGGCT CAACCAGCCCCAGCCCGACTTCACCAAGAATCGCTCGGGCTTCATCCTCAGCGTGCCCGGGAACTGACGCCCCGCGGAGGCCTGGCCCGG AGCCCGGCCACACTCCGAGTCCTGGGTCCCAGTCCAGCTGCTGCCTCCCAACCCATGCCCGCTAGAAACCTGCTGCGAGGGCCCCTCCCA GAGGAGCCCCGCCCCTGTAAGATTTCCTTCCTGGTTTTCTGCCTTTGGTATCATCTTCCTCTGTCCTTACTGTCCACGGTCCCTGTTCAA TAAGCCAAAGACCCTGGTGCCCCGCCCAGACCCCTGGGCTGACGTCCAGACCAATCTCACCCCAGAGGCAACTGGATGGTGCCTTTAGTT GGTGCGGATGCCCCGTGGCCAGGTCAAGTCAGAGCACCTGGACAGGTGTCCTCCCTGCTGCTGACCCTGCAGAGGGAAGGGGTGGGGATG CAGGACCCCACTCTGCGGGAGCCCCATAGCCACCTCTCTTGCCCAAGGTGAGCCAGCCCTGGGGACCCAGCTCAGGGAGGCTCTGCTCAG AGTTCGGCGGACCCACCCCAACCCAACTCCCAGCCGCCAGCCAAAGCCACTGGGTGAGCAGAGTCACCCACAGGGCCAGCCCCTCAGCCA GGAGCCAGTGGCAGGAGCGGAACAGCCCATCCAGCAGAGTGAGTCCATCCTTCCCAGGTTCTCCCCTGGGAGACTCCCTTTGCCACCAAG GCCCCCACCAGGGCCTCTGACCACCGCTCTGGAGAGGACAGTGTGGCATGCTCCAAGGATCATCTTACTTAACTCGCAGCCTGTGGCTGT GGTCCTCTTATAGATACTTTCACCGTTTGCAGGGTTGCTAATCAGATACCTGCTGTCACCACACTTGGGTCAGGAACCCTAATGAGAACG GGGAGCTGCCAGGGTGAGGGCAGCCCTCAGGGTCGGCCGCTTTCCCTCTGGACCACCTCCCGCTGCGTTTCCTACTCAGAGAAACAGCAA GGGCGGGGTCAAGACACGGGATGACGGGAAGCAGGAAGCGGGGCAGCAGCACAGCGTGGGGTCCTGGCACTGCAGGCCAGGCCAGGATGC CCACCCCGCCCTCTACACGGCCCCTTGGGGCCTGCGCCCGTGAAACTGGTGCCAGGGAGCACTGCCAGCTTGCCAGTTTCTGCCCAGCAA AAGCACGTATGCTTCAGGGGCCTTCTGAGACCACCTTCCCCACTGAGCCCCAGCTGCTGAGAAGGCCTTGAGGGAAGTAGAGGCTGGGAG CAAATGCCCCATGCGGTGAGAGGATGAGGGGAGCCTACGCCTCAGGCATGTGGTGAGAGGATGAGGGGGAGGGAGCCAACGCCTCAGGTG GAGTGGGCAGAGGTGCAAGAGAGGGATGTACTGAAGCTTCTTCCCGTCCTGCCACAGACACTTCTCCTGCCTTCCCACCCTGACCCGGCA GAACCCACCAAGTGCCTGTGTGCAGCCTCCTGTGCCTCACCCAGGGCCTGACCCCAGAGTGGTCCCAACAACCCGGTCTCATGCCCACTC CCCATCCCTGCTTCCCAAAAATTGCACTGTGTGCAGTTTGCAACAAAGAATCCCGCTGGCATCCTGTCCTTGGGAACCCTTTCTCATTCT CCAAGCCTGGTCAGCTGCCTGCACAGGCAGAGGTGCCCTCAGCCCAGATTAGCAACACTCATAGTTTTGCCAATTACCAGTAGACACTAG TGGAACCATCTAACTGGAACTTCCTCTCTCCTTCCACTTATTTCCTCAAACTTGTTGCTTTACACTAGACACATGCAAATGTATGTTTTA AACACACCAAAACAGATCATGCCAAATGAGTTGCCTGTCAAAGGCTGGAGGGCAGGAGGAGGGCCTGGGTTTGGGTTCTTTCCTCCCAGC CTTTGGATGGTGCCTTGGGCCCCTTAGCCCCAGCGCCAGGGCCTCCCAGCTGAGGCCACAGGACAAGCACTTTTTTATGATGTACTAAAA GCCACAGTATGTGGCAACTGCAAAAGGATCAGGAATTTAGGGTATGATCTCGGTCACGTGTCCCGGGCGCTGAGGGGAAAGGAAGCGGGC ATGATTGTAGACAATGAGGGGGTTCTCTTGATGTAATGAAATGCAATTTTATGGTTTGGTGCAAAAACTCCTATTTTCCAGTAAATTAAC TTTATTTCTAAAGCATATTTTGATTTGCCATCAAGAGCAATAAAGCATTAAATCTTATTTTTAAAGGTGTTCTGCTTATCTGTCACTGAA |
Top |
FusionGenePPI for TADA2A_MYO1D |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TADA2A | EXOC8, FAM107A, HGS, TADA3, MYC, NR3C1, KAT2A, ATXN7, TP53, CTNNB1, KAT2B, MED1, MED26, CCDC101, ERCC4, CDK8, SRSF1, DDX3X, LUC7L, RNF41, DHX16, DDB1, MED29, TRIM28, SNRPA, SSB, NCBP1, PRPF6, CDC40, SRSF3, WDTC1, RBM39, MED30, MED28, PSPC1, TRA2B, TRA2A, RALY, NONO, PRRC2B, PLRG1, HELT, SRSF4, XAB2, MED8, PUF60, MED25, DHX15, RNPS1, SRSF5, EIF3H, SRRM1, LRCH4, MYEF2, RBM14, EIF3I, MED20, EIF3C, EIF3M, SIN3A, EIF3B, EIF3L, PRPF19, HNRNPC, ILF3, CDC5L, AKAP8, MED18, SNW1, HDAC1, MARK3, PABPC1P1, C11orf30, KRT8, POLR2A, SRRM2, MED16, ILF2, HSPA5, MED14, MED31, LUC7L3, DDX5, MED4, SFPQ, MED15, MED17, DDX17, POLR2B, WDR5, HNRNPF, ACTC1, DOCK6, LUZP1, MED27, POLR2C, HNRNPM, MARK2, MED22, MED23, ZZZ3, MED6, MED12, MED13, YEATS2, DR1, MBIP, SUPT3H, TCF3, PAXIP1, HSP90AA1, HNF4A, LYN, MCPH1, USP22, ARNT2, PRKAB2, KPNA2, MAGOH, MFAP1, EIF4E2, MTX2, FARS2, SF3A3, ZFYVE26, PPP1R16B, PRPF31, CCHCR1, C1orf109, CDCA7L, GPSM3, TTC23, FBF1, KLC4, LOC149950, TEKT4, ZNF564, TTC9C, KLHL38, FAM127C, PSME3, CARD8, PSMC3, IKZF5, CDH19 | MYO1D | ILK, PELO, SIRT7, FBXO25, CUL1, LRRK2, UBASH3B, SHC1, ATP6V1B1, ECT2, MDC1, PAXIP1, PAN2, CCDC8, EGFR, DAPK1, PEX19, VSIG4, UBB, TBC1D9B, PTEN, ZNF746, SSH1, SSH2, PSMC4, DKK3, FBXO40, TOR1AIP2, BTD, HAVCR2, EID1, NEXN, SCN3B, SSSCA1, CDH5, DNAI2, PPP6R2, LSP1, BBS7, COX15, DLST, PDHA1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TADA2A_MYO1D |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TADA2A_MYO1D |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | MYO1D | C0004352 | Autistic Disorder | 1 | CTD_human |